Table 1.
2002–2006 | 2007–2011 | 2012–2016 | 2017–2021 | Total | |
---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | n (%) | |
Cases | 5524 (40.4) | 6596 (48.2) | 1196 (8.7) | 363 (2.7) | 13,679 (100) |
Sex | |||||
Male | 2991 (54.1) | 3916 (59.4) | 654 (50) | 193 (54.0) | 7754 (56.7) |
Female | 2533 (45.9) | 2680 (40.6) | 542 (50) | 170 (46.0) | 5925 (43.3) |
HA-related deaths | |||||
n | 2 | 3 | 0 | 0 | 5 |
Mortality 1 | 0.02 | 0.04 | 0 | 0 | 0.06 |
Average Incidence (95% CI) 1 | |||||
Republic of Serbia | 14.8 (14.4–15.2) | 18.0 (17.6–18.5) | 3.4 (3.2–3.6) | 1.0 (0.9–1.1) | 9.5 (9.3–9.6) |
Vojvodina | 13.2 (12.5–13.9) | 10.6 (9.9–11.2) | 2.8 (2.4–3.1) | 0.7 (0.5–0.8) | 7.0 (6.7–7.2) |
Central Serbia | 15.4 (14.9–15.9) | 20.7(20.2–21.2) | 3.6(3.3–3.8) | 1.2(1.0–1.3) | 10.4(10.2–10.6) |
Average Sex-specific Incidence (95% CI) 1 | |||||
Male | 16.5 (15.9–17.1) | 22 (21.3–22.7) | 3.8 (3.5–4.1) | 1.1 (1.0–1.3) | 11.0 (10.8–11.3) |
Female | 13.2 (12.7–13.7) | 14.3 (13.7–14.8) | 3.0 (2.7–3.2) | 1.0 (0.8–1.1) | 8.0 (7.8–8.2) |
1 per 100,000 population.